ENLIVEN THERAPEUTICS INC ELVN

US Healthcare Pharmaceutical Preparations
$49.82
+2.2%
52w: $15.14 – $50.85

Latest 13F among current holders filed 30 days ago (Jun 4, 2026)

Price — last 12 months

research preview data
15.1432.9950.85
Jun 20, 2025 Jul 2, 2026
Institutional holders
172
+44 QoQ
13F value
$2.46B
+156.2% QoQ
Smart-money holders
26
signal tier ≥ 2
New smart buyers
11
Q1 2026
Options barometer
3.0×
$48.3M calls / $16.1M puts

Institutional value by quarter

$792.2M
Q1 2024
$1.14B
Q2 2024
$1.22B
Q3 2024
$1.12B
Q4 2024
$983.9M
Q1 2025
$1.19B
Q2 2025
$1.22B
Q3 2025
$960.9M
Q4 2025
$2.46B
Q1 2026

Number of holders

75
Q1 2024
95
Q2 2024
104
Q3 2024
116
Q4 2024
124
Q1 2025
127
Q2 2025
135
Q3 2025
128
Q4 2025
172
Q1 2026

Who owns ELVN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
ORBIMED ADVISORS LLC ★2Fundamental diversified8.0M$312.0M7.1%Held
FMR LLC Long only active6.8M$267.7M0.0%-3.9%
Polar Capital Holdings Plc Other5.1M$198.6M0.9%+44.2%
BlackRock, Inc. Index provider3.7M$144.4M0.0%+2.0%
Commodore Capital LP ★3Fundamental concentrated3.3M$128.4M7.4%-30.2%
Vestal Point Capital, LP ★2Fundamental diversified3.3M$127.4M3.6%-15.1%
Bellevue Group AG ★2Fundamental diversified2.3M$91.0M2.2%New
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical2.2M$85.0M0.0%
Fairmount Funds Management LLC ★3Fundamental concentrated1.9M$72.7M5.3%-50.0%
CITADEL ADVISORS LLC Multistrat pod1.7M$68.4M0.0%+22.4%
Venrock Adviser, LLC ★3Fundamental concentrated1.7M$67.7M2.5%-46.5%
NOVO HOLDINGS A/S ★3Fundamental concentrated1.3M$50.2M4.1%-13.5%
STATE STREET CORP Index provider1.1M$42.8M0.0%+3.6%
GEODE CAPITAL MANAGEMENT, LLC Index provider1.1M$41.8M0.0%+1.7%
Pictet Asset Management Holding SA Diversified mechanical929.5K$36.4M0.0%-28.7%
BAKER BROS. ADVISORS LP ★2Fundamental diversified905.2K$35.5M0.2%+233.5%
Rock Springs Capital Management LP ★2Fundamental diversified826.5K$32.4M1.9%+3.5%
Avidity Partners Management LP ★2Fundamental diversified800.0K$32.2M3.4%+470.2%
Siren, L.L.C. ★2Fundamental diversified746.2K$29.3M0.8%New
STEMPOINT CAPITAL LP ★2Fundamental concentrated726.9K$28.5M2.8%New
DIMENSIONAL FUND ADVISORS LP Quant stat arb681.7K$26.7M0.0%+70.9%
First Turn Management, LLC ★2Fundamental diversified623.8K$24.5M2.7%New
Candriam S.C.A. Other594.1K$23.3M0.1%+31.1%
Jones Hill Capital LP ★3Fundamental concentrated593.0K$23.2M5.0%
Affinity Asset Advisors, LLC ★2Fundamental diversified586.9K$23.0M1.4%New
Logos Global Management LP ★2Fundamental concentrated540.0K$21.2M1.1%+58.8%
MORGAN STANLEY Bank broker518.6K$20.3M0.0%+25.9%
GOLDMAN SACHS GROUP INC Bank broker473.1K$18.5M0.0%+99.5%
NORTHERN TRUST CORP Index provider372.3K$14.6M0.0%+5.7%
Caption Management, LLC Quant stat arb370.0K$14.5M0.7%New
Capricorn Fund Managers Ltd ★2Fundamental diversified369.4K$14.5M2.3%New
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider360.6K$14.1M0.0%+1.5%
MILLENNIUM MANAGEMENT LLC Multistrat pod345.3K$13.5M0.0%+16.3%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical331.0K$13.0M0.0%
ADAR1 Capital Management, LLC Other329.5K$12.9M0.8%+998.5%
Spruce Street Capital LP ★2Fundamental concentrated329.0K$12.9M3.1%-26.2%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical312.8K$12.3M0.0%
Balyasny Asset Management L.P. Multistrat pod310.0K$12.2M0.0%New
JENNISON ASSOCIATES LLC Other309.2K$12.1M0.0%New
ALLIANCEBERNSTEIN L.P. Long only active771.9K$11.9M0.0%+1995.2%
Woodline Partners LP Other301.7K$11.8M0.0%+0.2%
UBS Group AG Bank broker283.5K$11.1M0.0%+390.0%
Soleus Capital Management, L.P. ★2Fundamental diversified230.9K$9.1M0.4%-77.5%
Exome Asset Management LLC ★2Fundamental diversified220.1K$8.6M5.1%-1.0%
Schonfeld Strategic Advisors LLC Multistrat pod218.9K$8.6M0.1%New
First Light Asset Management, LLC ★3Fundamental concentrated201.9K$7.9M0.7%New
Patient Square Capital LP ★2Fundamental concentrated200.0K$7.8M1.4%-35.1%
D. E. Shaw & Co., Inc. Quant stat arb193.5K$7.6M0.0%New
Connor, Clark & Lunn Investment Management Ltd. Diversified mechanical191.3K$7.5M0.0%-1.8%
Nicholas Investment Partners, LP Other182.7K$7.2M0.6%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.